Edward Shields, MD
Orthopaedic Surgery · Muskegon, MINPI 1952690257
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,830 of the $6,859 with a category attached, or 70.4%. Catalyst Orthoscience accounts for 70.4% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $4,929, more than ten times the $92 reported in 2019.
Across 25 payments — averaging $274.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Catalyst Orthoscience$5K
- Medwest Associates$1K
- Smith+Nephew$313
- Zimmer Biomet$189
- Stryker$55
- Pacira Therapeutics, Inc.$54
- plus $218 from 8 others
Across 6 payments — averaging $514.87 each. An ownership or investment interest held by the physician or an immediate family member.
- Catalyst Orthoscience$3K
What the payments were for
- Consulting fees$4,83070%
- Food & beverage$82912%
- Education$1,20017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Catalyst Orthoscience | 1 | $4,830 |
| Medwest Associates | 1 | $1,200 |
| Smith+Nephew | 3 | $313 |
| Zimmer Biomet | 2 | $189 |
| Stryker | 3 | $55 |
| Pacira Therapeutics, Inc. | 4 | $54 |
| Alimera Sciences, Inc. | 2 | $49 |
| Johnson & Johnson | 2 | $43 |
| Radius Health, Inc. | 2 | $37 |
| Avanos Medical | 1 | $30 |
| Abbott | 1 | $26 |
| Embody, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Meditrina | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,859 in reported general payments places this provider in the 65th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 152 | $991 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 229 | $905 |
| Diclofenac Sodium | 45 | $811 |
| Celecoxib | 46 | $600 |
| Ibuprofen | 92 | $285 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $147 |
| Tramadol Hcl | 40 | $66 |
| Meloxicam | 24 | $59 |
| Cephalexin | 34 | $53 |
| Amoxicillin | 24 | $15 |
| Diazepam | 11 | $8 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Muskegon
- Anthony BozzioMuskegon$518K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.